Arsenic (As) contamination in water or food is a global issue affecting hundreds of millions of people. Although As is classified as a group 1 carcinogen and is associated with multiple diseases, the individual susceptibility to As-related diseases is highly variable, such that a proportion of people exposed to As have higher risks of developing related disorders. Many factors have been found to be associated with As susceptibility. One of the main sources of the variability found in As susceptibility is the variation in the host genome, namely, polymorphisms of many genes involved in As transportation, biotransformation, oxidative stress response, and DNA repair affect the susceptibility of an individual to As toxicity and then influence the disease outcomes. In addition, lifestyles and many nutritional factors, such as folate, vitamin C, and fruit, have been found to be associated with individual susceptibility to As-related diseases. Recently, the interactions between As exposure and the gut microbiome have been of particular concern. As exposure has been shown to perturb gut microbiome composition, and the gut microbiota has been shown to also influence As metabolism, which raises the question of whether the highly diverse gut microbiota contributes to As susceptibility. Here, we review the literature and summarize the factors, such as host genetics and nutritional status, that influence As susceptibility, and we also present potential mechanisms of how the gut microbiome may influence As metabolism and its toxic effects on the host to induce variations in As susceptibility. Challenges and future directions are also discussed to emphasize the importance of characterizing the specific role of these factors in interindividual susceptibility to As-related diseases.
Introduction
As a ubiquitous metalloid element in the earth, arsenic (As) is widely distributed in water and soil, and over 200 million people are affected by As contamination (Naujokas et al. 2013) . Chronic As exposure is associated with a series of diseases, such as cardiovascular diseases, neurological disorders, liver diseases, skin lesions, and diabetes mellitus, and multiorgan cancers, such as bladder cancer, skin cancer, and lung cancer (Naujokas et al. 2013 ). It is clear that As exposure can cause significant health hazards, and in particular, a proportion of exposed people have higher risks of developing As-related diseases (Chen et al. 2005; Hernández and Marcos 2008) . The marked interindividual variability in the susceptibility to As was also observed among an exposed population with similar exposure history, socioeconomic status, and diet (Ghosh et al. 2006; Banerjee et al. 2007) . Previous studies found that many factors, such as host genetics, nutrition status, and lifestyle, could affect the susceptibility of an individual to As-related diseases (Hernández and Marcos 2008; Yu et al. 2016b; Chen et al. 2006 ). The variants of host genes induce the variabilities in the metabolism and eliminating efficiency of As and cause different sensitivities and tolerances to As-induced damage (Hernández and Marcos 2008) . In addition, certain nutritional factors affect As biotransformation, and its adverse health effects are also related to the individual susceptibility to As exposure (Yu et al. 2016b) . In recent years, gut microbiota has been concerned for its crucial role in the biotransformation and disease outcomes of multiple xenobiotics, such as pesticides, drugs, and As (Ilett et al. 1990; Spanogiannopoulos et al. 2016) . The gut microbiome has been shown to affect As biotransformation, but its composition and function can also be perturbed by As exposure (Lu et al. 2014a ; Van de Wiele et al. 2010) , both of which can influence the health of the host. However, the gut microbiome composition is highly variable between different individuals, which renders it a potential source of individual susceptibility to As-related diseases.
The specific aim of this report is to review the factors associated with As susceptibility and summarize the current knowledge of the interactions between the gut microbiome and As exposure to highlight the potential roles of the gut microbiome in As susceptibility.
As biotransformation in mammals and its pathogenic mechanisms
Inorganic arsenic (iAs) is the main form of As exposure and can be absorbed into our bodies by transporters located in the gastrointestinal tracts, such as the aquaporin 7/9 (AQP7/9), hexose permease, and phosphate transporter (Liu et al. 2004 (Liu et al. , 2006 Villa-Bellosta and Sorribas 2010) . The biotransformation of As in mammalian bodies is a very complex process, and the three different pathways that have been proposed (Hernández and Marcos 2008; Sun et al. 2014 ) are shown in Fig. 1 . Briefly, iAs V is first reduced to iAs III with the assistance of phosphorolytic enzymes such as purine nucleoside phosphorylase (PNP) (Radabaugh et al. 2002; Gregus et al. 2009 ). The first metabolic pathway, which is called the Challenger model, consists of a series of reduction and oxidative methylation reactions (Challenger 1945; Cullen 2014 (Cullen 2014; Cullen et al. 1984) . The third pathway was a variant of the second pathway and was first found in rats; iAs III binds to a protein to form AsS3-protein and is finally methylated to MMA V and DMA V (Sun et al. 2014; Naranmandura et al. 2006) . Arsenic (+ 3) methyltransferase (AS3MT) is the main enzyme conducting As methylation in the human body (Dheeman et al. 2014) . GSTOs can catalyze the transform from As V to As III , but previous studies indicated that GSTO-conducted As reduction was relatively limited and some other genes played important role in this process (Tanaka-Kagawa et al. 2003; Chowdhury et al. 2006) . Most of the As is pumped out of cells by the multiple drugresistance proteins MRP1 (encoding by gene ABCC1) and MRP4 (encoding by gene ABCC4) and is finally excreted with urine (Banerjee et al. 2014) . As transport pathways and related genes have been summarized by a recent review (Roggenbeck et al. 2016 ).
Multiple pathogenic mechanisms of As have been proposed. For example, As exposure can increase the reactive oxygen species (ROS) level in cells to cause oxidative stress (Ding et al. 2005) , which can further induce DNA damage and lipid peroxidation. In addition, As can inhibit the activities of certain key enzymes, such as pyruvate dehydrogenase and GSH reductase, by conjugating with thiol (Petrick et al. 2001) . As exposure can also alter DNA methylation, damage DNA repair, and perturb cell proliferation signals (Hughes 2002) . Previous studies have also demonstrated the immunotoxic effects of As (Dangleben et al. 2013 ).
Host genetic variations affect As susceptibility
Host genetic variation is one of the main factors related to the variability in interindividual susceptibility to As toxicity. According to previous studies, three types of genes are mainly involved, including genes related to As transportation and biotransformation, genes involved in the oxidative stress response and DNA repair, and other genes including p53 and NALP2 (Faita et al. 2013) .
Genes related to As transportation and biotransformation
As toxicity is known to be largely determined by its methylation state and valence state (Styblo et al. 2000) . Generally, the trivalent species iAs III , MMA III , and DMA III are much more toxic than the pentavalent species iAs V , MMA V , and DMA V (Styblo et al. 2000; Naranmandura et al. 2007; Hirano et al. 2004) . Moreover, methylated pentavalent species MMA V and DMA V are less toxic than iAs V (Hirano et al. 2004) . Therefore, As metabolism, especially As methylation, is considered a detoxifying process, and the efficiency of As biotransformation partly determines the host tolerance to As exposure. In fact, individual As susceptibility has been shown to be associated with variations in genes involved in As metabolism, namely, PNP, AS3MT, GSTO1, GSTO2, MTHFR (encoding methylenetetrahydrofolate reductase), and CBS (encoding cystathionine β-synthase) (Ahsan et al. 2007; Chaudhuri et al. 2008; Steinmaus 2010) . The urinary As profile is a widely used indicator of As methylation efficiency, As metabolic status, and As toxic effects in the host.
PNP was previously thought to be involved in reducing iAs V to iAs III (Radabaugh et al. 2002; Gregus et al. 2009 ). A previous study carried out in 428 subjects exposed to As in West Bengal (India) found that polymorphisms of PNP, including His20His, Gly51Ser, and Pro57Pro, were significantly associated with As-induced skin lesions in an Indian population (Chaudhuri et al. 2008) . Moreover, in another study with 384 cases and 479 controls in Taiwan, Gly51Ser and Pro57Pro of PNP were found related to the increased risk of carotid atherosclerosis in high As (> 50 µg/L)-exposed population (Hsieh et al. 2011) . However, previous studies indicated that catalyzing the reduction of As V to As III is only one of the functions of PNP, and it is not necessary for As reduction that some other enzymes are also involved in this process in mammals (Gregus and Németi 2002; Thomas 2010; Antonelli et al. 2014 ). Therefore, the relationship between polymorphisms of PNP and As susceptibility need to be further verified. AS3MT is the key enzyme that catalyzes the methylation of trivalent species, and its polymorphisms are highly associated with As methylation efficiency (Chaudhuri et al. 2008) . For example, AS3MT Met287Thr polymorphisms have been found to strongly correlate with AS3MT activity . Further study indicated that AS3MT with Met287Thr has different As methylation efficiencies compared with the wildtype, that it has significantly lower V max and K m values for iAs III than the wild-type enzyme in the absence of GSH (Ding et al. 2012) . Met287Thr polymorphisms were associated with As-induced micronucleus frequency as well as with the risk of development of skin lesions and bladder cancer (Beebe-Dimmer et al. 2012; Hernández et al. 2014; Das et al. 2016) . GSTOs also partly participate in As metabolism and detoxification in mammals. A case-control study found that GSTO1 genotypes were associated with skin lesions (Ahsan et al. 2007 ). In a study that analyzed urinary As speciation and single-nucleotide polymorphism of 247 subjects exposed to As in southwestern Taiwan, GSTO1 Ala140Asp was associated with lower levels of MMA in urine, which correlated with metabolic syndrome (Chen et al. 2012a ). In addition, a hospital-based case-control study with 149 urothelial carcinoma (UC) cases and 251 healthy controls in Taiwan found that a homogenous variant polymorphism Asp142Asp of GSTO2 was inversely associated with the risk of UC (Chung et al. 2011) . However, there are also many studies that did not find any association between GSTO polymorphisms and As-related diseases (Hernández and Marcos 2008; Faita et al. 2013; Antonelli et al. 2014) . For example, a study with 415 subjects from Hungary, Romania, and Slovakia failed to detect a significant association between polymorphisms in GSTO1 and the alteration of urinary arsenic metabolite pattern (Lindberg et al. 2007) .
In addition to genes directly involved in As biotransformation, polymorphisms of multiple genes involved in one-carbon metabolism also influence As susceptibility. As shown in Fig. 1 , MTHFR catalyzes the conversion of 5,10-methylenetetrahydrofolate (5,10-methyl-THF) to 5-methyltetrahydrofolate (5-methyl-THF) to promote the formation of S-adenosylmethionine (SAM), which is the methyl donor of As methylation (Gamble et al. 2005) . Interestingly, MTHFR C677T genotypes were found to be associated with lower blood folate concentrations according to a meta-analysis study (Tsang et al 2015) , and multiple studies also found MTHFR polymorphisms correlated with the urinary As profile (Hernández and Marcos 2008; Faita et al. 2013) . A case-control study carried out in 492 exposed people (219 bladder cancer cases and 273 controls) in Southeastern Michigan found that MTHFR 222Ala allele was associated with the lower risk of bladder cancer (Beebe-Dimmer et al. 2012) . Moreover, the sensitivity of As embryotoxicity was enhanced in the MTHFR knockout mouse (Wlodarczyk et al. 2014) . Another related gene is CBS, which catalyzes the conversion of homocysteine to cystathionine. Homocysteine can be used to generate SAM and cystathionine to participate in GSH production (Jhee and Kruger 2005) . The activity of the CBS gene influences the balance of one-carbon metabolism and thus influences As methylation (Steinmaus 2010) . Furthermore, variant genotypes for CBS SNPs (rs234709 and rs4920037) have been found to be associated with the level of urinary MMA and As-induced lung cancer according to two studies in Argentina. One study had 45 lung cancer cases and 75 controls, and the other one had 58 lung cancer cases and 84 controls, respectively (Steinmaus 2010; Porter et al. 2010) .
In addition, the ability to eliminate As can also influence the toxic effects of As. In the human body, MRP4/ ABCC4 is mainly responsible for the export of methylated As from hepatocytes to the blood and from renal proximal tubular cells to urine (Banerjee et al. 2014) . A recent study expressed multiple MRP4 variants (C171G-, G187W-, K304N-, Y556C-, and wild-type MRP4) in human embryonic kidney cell line and found that the As transporting capacities of them were highly variable; these variants were also related to interindividual differences in As susceptibility .
Additional As susceptibility-related genes and studies involved in As transportation and biotransformation are summarized in Table 1 .
Genes involved in oxidative stress
Genes that protect against As-induced adverse effects, especially oxidative stress response genes and DNA repair genes, also contribute to the variability in As susceptibility. For example, glutathione S-transferases (GSTs, including GSTM1, GSTT1, and GSTP1) conjugate the reduced GSH to xenobiotic substrates for the purpose of detoxification, and the polymorphisms of GST genes are related to the susceptibility to oxidative stress (Hernández and Marcos 2008) . According to a study in Taiwan with 115 exposed subjects and a study in Argentina with 170 exposed subjects, people with the GSTM1 null genotype had a higher proportion of urinary MMA and iAs (Steinmaus et al. 2007; Chiou et al. 1997) . Another study carried out in 422 As-exposed subjects in West Bengal (India) indicated that the risk of As-induced skin lesions among people with at least one functional allele of GSTM1 was significantly higher than that of people with the GSTM1 null genotype (Ghosh et al. 2006) . For GSTT1, a study which completed the genotyping of 1062 subjects in Bangladesh indicated that the homozygous wide-type genotypes were associated with a high risk of As-induced skin lesions (McCarty et al. 2007b) , while this association was not detected in studies conducted in China (354 exposed subjects from two different clans) and India (422 exposed subjects) (Ghosh et al. 2006; Lin et al. 2007) . A study in Taiwan with 70 cases and 209 controls suggested that the null genotype of GSTT1 was associated with skin cancer (Hsu et al. 2015) . In addition, some studies suggested that polymorphisms of GSTP1 were associated with As-induced skin lesions (McCarty et al. 2007b; Lin et al. 2006) . While the Ile105Val variant of GSTP1 was found to be associated with carotid atherosclerosis, a recent study did not find an association between this variant and either the blood or urinary As levels of 95 Turkish male smelter workers with occupational As exposure (Kaya-Akyüzlü et al. 2016; Wang et al. 2007) . Data collected from different areas and from subjects with different backgrounds are not always consistent; as such, future studies are required to elucidate the association between GST polymorphisms and As-related diseases.
In addition, the influence of polymorphisms of some oxidative stress response genes, including myeloperoxidase (MPO) and catalase (CAT), on the risk of As-induced skin lesions was assessed by a case-control study in Bangladesh with 30 cases and 104 controls (Ahsan et al. 2003) . It found that G463A of MPO and C262T of CAT were associated with a higher risk of As-induced skin lesions. Likewise, heme oxygenase-1 (HO-1) is also an antioxidant enzyme that can be induced by oxidative stress (Choi and Alam 1996) , and multiple studies in Taiwan indicated that HO-1 GT-repeat polymorphisms significantly were associated with As-related carotid atherosclerosis, cardiovascular mortality, and skin cancer (Wu et al. 2010 (Wu et al. , 2011 (Wu et al. , 2014 . In addition, according to a study in Taiwan carried out in 65 cases and 189 controls, Tyr113His polymorphisms in another related gene, microsomal epoxide hydrolase 1 (EPHX1), also significantly correlated with As-induced skin cancer (Hsu et al. 2015) .
Genes related to DNA repair
Inducing genotoxic damage and inhibiting DNA repair pathways are two of main aspects of As toxicity (Hughes 2002) . Therefore, the association between DNA repair-related genes and As susceptibility has been widely explored. The base excision repair pathway is one of the major DNA repair pathways in humans for repairing ROS-induced DNA damage (Thompson et al. 1990; Wood et al. 2001; Frosina 2004 ). Previous studies found that polymorphisms of multiple genes, including 8-oxoguanine DNA glycosylase (OGG1), apurinic/apyrimidinic endonuclease (APE1), and X-ray and repair and cross-complementing group 1 and group 3 (XRCC1 and XRCC3), were associated with individual susceptibility to As-induced diseases (Hernández and Marcos 2008; Faita et al. 2013) . For example, a study 
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Other genes
In addition to the genes we mentioned, several other genes were also found to strongly correlate with the individual susceptibility to As-induced diseases. First, the correlation between the tumor suppressor p53 gene and As susceptibility has been widely discussed. Multiple studies demonstrated that Arg72Pro polymorphisms of the p53 gene were associated with different As methylation capacities and the different risks of As-related keratosis (Chaudhuri et al. 2006; Huang et al. 2011) . Interestingly, Arg/Arg of p53 Arg72Pro was suggested over represented in people with keratosis according to a study in India with 366 exposed subjects (Chaudhuri et al. 2006 ), but the other study in Taiwan indicated that people with Arg/Arg of p53 Arg72Pro had lower risk of As-induced renal cell carcinoma (RCC) than those with Arg/Pro and Pro/Pro (Huang et al. 2011) . Moreover, As is also known to profoundly affect the immune system and induce disorders. Several studies in India (West Bengal) indicated that variations in certain related genes were associated with As susceptibility. For example, a case-control study found that polymorphisms of TNF-α (tumor necrosis factor alpha) and IL-10 (interleukin 10) were associated with the risks of As-induced skin lesions, ocular, and respiratory diseases and that the high TNF-α producing genotype (GA/AA of G308A) of TNF-α and the low IL-10 producing genotype (TA/AA of T3575A) of IL-10 were implicated in high disease risk (Banerjee et al. 2011) . Moreover, the Ala1052Glu polymorphism of the NALP2 (LRR and PYD domain-containing protein 2) gene was found associated with fewer chromosomal aberrations and low risk of Asrelated respiratory diseases and skin lesions according to a case-control study with 219 cases and 213 controls in West Bengal (India) (Bhattacharjee et al. 2013) . A detailed list of host genes related to As susceptibility and related studies is found in Table 2 .
Other factors related to individual susceptibility
In addition to host genetics, other factors, such as nutritional factors and lifestyles, also play an important role in As metabolism and its toxic effects, thus, are also related to As susceptibility (Chen et al. 2006; Mitra et al. 2004; Hall et al. 2009 ).
Diet and nutrients
Multiple studies indicate that diet and nutrients can deeply affect the As metabolism and its toxic effects. Although the mechanisms are not fully understood, there are three potential mechanisms that diet and nutrients could influence As exposure. First, some nutritional factors, such as trace elements selenium (Se), iron (Fe), and Zinc (Zn), can alter the bioaccessibility of As (Yu et al. 2016b ). For example, low concentration of Se can bind As and form As-Se compound [(GS 3 ) 2 AsSe] − , which can be excreted from body (Sun et al. 2014) . Likewise, Zn supplement co-administrated with Se can increase As excretion in cattle that decrease As in milk but increase As in hair and feces (Dash et al. 2013) . Fe can be used to precipitate As, and a recent study demonstrated that sulfates of Fe 2+ and Fe 3+ could efficiently decrease the solubility of iAs and DMA V in aqueous solution in a static in vitro model of gastrointestinal digestion (Clemente et al. 2016; Raposo et al. 2006) . Second, some diet and nutrients can directly participate the As metabolism in host bodies. A typical example is the B type vitamins, especially folic acid. Taiwan; 894 Short GT-repeat HO-1 short allele is associated with a low risk of cardiovascular mortality in people with hypertension Wu et al. (2010) Taiwan; 787 Short GT-repeat HO-1 short allele is associated with a low risk of carotid atherosclerosis Hsu et al. (2015) Taiwan; 280 Short GT-repeat No association with skin cancer Folic acid is a type of B vitamin and plays an important role in one-carbon metabolism, which is related to SAM synthesis ( Fig. 1 ) (Fox and Stover 2008 ). An increase in folate intake can reduce blood As and increase DMA in urine, while a decrease in folate intake is associated with a high risk of As-induced skin lesions (Mitra et al. 2004; Gamble et al. 2007 ). Likewise, administration of GSH, which is an important substrate in As metabolism, can decrease the level of MMA and total As in blood and brain of mice (Wang and Zhao 2009 ). Thirdly, As toxic effects can be profoundly modulated by some nutrients. Multiple studies demonstrated that the administration of antioxidants, such as vitamins C (ascorbic acid), vitamin E (α-tocopherol), GSH, and N-acetylcysteine (NAC), can protect organs from As toxicity (Yu et al. 2016b; Ramanathan et al. 2002; Reddy et al. 2011) . For example, a previous study demonstrated that As could improve nitric oxide and ROS generation, and increase lipid peroxidation in brain cells, but those adverse effects can be relieved by vitamins C, E, and chelator dimercaptosuccinic acid (Chattopadhyay et al. 2002) . Tea, which contain tea polyphenols as antioxidants, can reduce As-induced oxidative stress and DNA damage according to previous animal studies (Sinha et al. 2003 (Sinha et al. , 2010 Maiti 2017) . Likewise, Zn administration could decrease lipid peroxidase and increase the activities of superoxide dismutase, glutathione peroxidase, glutathione reductase, and catalase, which ameliorated As-induced oxidative stress and thus decrease As-induced hepatotoxicity (Kumar 2010) . Besides, according to McCarty et al., fruit consumption is associated with a reduced risk of As-induced skin lesions, whereas bean and betel nut are associated with an increased risk of this disease (McCarty et al. 2006 ). Previous epidemiological studies in Taiwan found that serum carotene levels were associated with several As-related diseases, such that low serum carotene level was significantly associated with a high risk of As-induced skin cancer and blackfoot disease (Hsueh et al. 1997 (Hsueh et al. , 1998 . On the other hand, some diets could enhance the As toxic effects. For example, high-fat diet can deteriorate As-induced oxidative stress in rat heart and liver and exaggerated hepatofibrogenesis in mice caused by chronic As exposure (Dutta et al. 2014; Wu et al. 2008) . A recent study indicated that highfat diet increased the sensitivity of mice to iAs exposure to increase hepatotoxicity (Hou et al. 2017) . A recent review summarized the effects of diet and nutrition factors on As metabolism and toxicity (Yu et al. 2016b ).
Lifestyles
Lifestyle is another factor that can influence As toxicity and thus related to individual susceptibility to As-induced diseases. For example, according to previous studies, there are synergistic effects between As exposure and smoking on the risk of lung cancer as well as skin lesions (Chen et al. 2004 (Chen et al. , 2006 Järup and Pershagen 1991) . On the other hand, exercise might be helpful to fight against the adverse effects of As exposure. An animal study indicated that swimming exercise could prevent As-induced impairment of long-term memory of object recognition in mice (Sun et al. 2015) .
Gut microbiome and As susceptibility

Gut microbiome introduction
With trillions of microbes in the human gastrointestinal tract, there are 100 times more genes in the gut microbiome than those in the human genome. As such, the Ala1052Glu polymorphism is associated with low risks of skin lesions, respiratory diseases, and chromosomal aberrations a All numbers in parentheses are reference number gut microbiome is considered the second genome of the human body (Consortium 2012; Gill et al. 2006; Bäckhed et al. 2005; Eckburg et al. 2005) . The gut microbiota plays important roles in food digestion, host energy homeostasis, and immune system development and has complex interactions with the neural system (Nicholson et al. 2012; Guarner and Malagelada 2003) . In addition, the large gene pool of the gut microbiome confers powerful xenobiotic biotransformation ability (Ilett et al. 1990; Koppel et al. 2017) . Bacteria-conducted biotransformation can deeply alter the toxic effects of certain xenobiotics, including drugs and heavy metals (Lindenbaum et al. 1981) . For example, nitrazepam, a hypnotic drug used in the treatment of insomnia, can be transformed to 7-aminonitrazepam by gut microbiota and then be transported to be metabolized to 7-acetylaminonitrazepam, a compound with teratogenicity (Takeno and Sakai 1991) . Chromium (Cr) is another typical example of bacteria-conducted biotransformation; gut bacteria have a powerful ability to reduce highly toxic Cr(VI) to the less toxic Cr(III), and this ability reduces the toxicity of Cr(VI) in drinking water (Suzuki et al. 1992 ). However, multiple environmental factors can also perturb the normal compositions and functions of the gut microbiome and are associated with a series of diseases such as obesity, glucose intolerance, and inflammation (Suez et al. 2014; Turnbaugh et al. 2006) . The oral route is the main approach of As exposure for humans, which renders the gut microbiota as the first batch of cells exposed to As. Accumulating evidence indicates that As exposure can alter the gut bacteria composition and that gut bacteria also influence the As metabolism in mammals (Lu et al. 2014a; Van de Wiele et al. 2010) . Since the gut microbiota plays a critical role in host metabolism, the interactions between As and gut bacteria could also further affect the host health status. However, the gut microbiome is known to be a highly dynamic system and that there is a wide variation in the bacterial composition between different groups of people (Schloissnig et al. 2013; Falony et al. 2016) . Therefore, this raises the question of whether the variation in gut microbiota is another factor that contributes to the individual susceptibility to As-induced disorders.
The interactions between gut microbiota and As have been widely discussed, and two main aspects have been proposed. First, accumulating evidence indicates that gut microbiota activities influence the bioaccessibility and biotransformation of As, which could influence the toxic effects of As on the host body (Van de Wiele et al. 2010; Rubin et al. 2014) . Second, studies show that As exposure can perturb the normal composition and functional gene profile of the gut microbiome and thus could potentially affect host health (Lu et al. 2014a; Chi 2017) . As such, both of these aspects could influence the individual susceptibility to As-induced diseases.
Gut microbiota conducts the presystemic As biotransformation and influences as bioaccessibility
As we mentioned earlier, gut microbiota-conducted biotransformation, known as presystemic metabolism, can largely modify the toxicity of xenobiotics and then influence the host tolerance. Previously, the As metabolic potency of mammalian gut microbiota has been investigated by Rowland and Davies, and the in vitro experiments indicated that rat gut bacteria could generate iAs III and DMA from iAs V (Rowland and Davies 1981) . Methylated and thiolated As species (MMA V , TMAO, TMAS, DMMTA, DMDTA V , MMTTA) were previously detected in experiments performed by incubating iAs with mouse gut microbiota (Chen et al. 1996; Kubachka et al. 2009; Kuroda et al. 2004; Pinyayev et al. 2011) . As metabolism by human gut microbiota was also explored. First, high-throughput sequencing data from the Human Microbiome Project (HMP) indicate that the genes related to As transportation and metabolism, such as Aqp, arsA, arsB, arsC, and arsD, are widely distributed in the genomes of human gut bacteria (Isokpehi et al. 2014) . Indeed, in vitro fermentation confirmed the As metabolizing ability of the human gut microbiota. For example, Van de Wiele et al. (2010) V by incubating iAs V or As-contaminated soil with in vitro cultured human colon microbiota, which suggested the existence of presystemic As metabolism in humans (Van de Wiele et al. 2010) . Another study proved that sulfatereducing bacteria (SRB) in human fecal and colon microbiota could convert MMA V to MMMTA V (Rubin et al. 2014 ) and that MMA V can be demethylated to iAs III by human colon microbiota, which highlights the complexity and multiple directions of presystemic As biotransformation. Since As toxicity is highly determined by its species, the gut bacteria involved in biotransformation should be able to modify the original toxicity of As exposure and influence the effects of As on the host. For example, DMMTA is a more cytotoxic species than DMA V in human epidermoid A431 cells (Naranmandura et al. 2007) . Moreover, previous studies also indicated that human gut microbiota could increase the bioaccessibility of As in soil particles (Yin et al. 2015; Laird et al. 2007 ). As bioaccessibility is the fraction of As dissolved in the gastrointestinal environment, which equates to the total As that can be absorbed by the human body (Ruby et al. 1996) . As an important parameter to evaluate the health risk of As, the increase of bioaccessibility may enhance the disease risk in humans.
However, there is a high variation in the gut microbiome composition observed between different individuals, and several factors could influence the composition profile 1 3 of gut microbiota. The high variability in microbiota may suggest the diversity of the As metabolic potency among different people. A recent study confirmed that the degree of As methylation by gut bacteria from different healthy individuals was largely different (Yin 2017) . Another in vitro study suggested that Fe 3+ decreased the As bioaccessibility and increased As methylation by altering the gut microbiota composition (Yu et al. 2016a) . Therefore, the variable potencies of presystemic As metabolism of different people might cause different healthy effects on the host body and might partially contribute to the observed variability in individual susceptibility to As-related diseases.
Gut microbiota influences host As metabolism and alters its toxic effects by supplying special metabolites
The gut microbiota is deeply involved in multiple physiological processes, and several necessary materials can be supplied by gut bacteria, such as short-chain fatty acids and multiple vitamins (Nicholson et al. 2012) , thus making it possible for gut bacteria to influence the toxic effects of As by modulating the host metabolism. For example, the gut microbiota has been considered an endogenous source of many vitamins including folate, riboflavin, cobalamin, and vitamin K (Rossi et al. 2011; LeBlanc et al. 2013; Hill 1997) . Multiple species in Bifidobacterium, such as Bifidobacterium adolescentis and Bifidobacterium pseudocatenulatum, can produce folate (Rossi et al. 2011) , whereas Bacillus subtilis and Escherichia coli can produce synthetic riboflavin (LeBlanc et al. 2013; Bacher et al. 2000) . These vitamins facilitate the processes of As methylation, DNA repair, and antioxidative stress (LeBlanc et al. 2013; Mukherjee et al. 2006; Tseng 2009; Schromm et al. 2000) . As we mentioned previously, previous studies indicated that increasing the intake of folate, riboflavin, and cobalamin could protect people from As-induced diseases, which is related to As susceptibility (Mitra et al. 2004; Hall et al. 2009 ). Our recent study found that in the low As-exposed gut microbiome, vitamin synthetic genes were largely enriched, suggesting a potential protective response to As exposure (Chi 2017) . Likewise, choline is an essential nutrient and can be transformed into betaine to remethylate homocysteine in the one-carbon metabolism pathway (Ueland et al. 2005) . A previous study found that the use of a low dietary choline supplement decreased the methylation of As in rabbit (Vahter and Marafante 1987) , whereas an increase in choline supplement was shown to promote As methylation in pregnant women, especially in women with low folate intake (Li et al. 2008) . Moreover, choline can also be derived from the gut microbiome (Nicholson et al. 2012; Martin et al. 2010) . The microbial synthesized vitamins and other metabolites may promote As metabolism and confer As resistance to the host. Therefore, besides directly conducting As biotransformation, gut microbiota also can influence As metabolism in host bodies, which suggests that different gut microbiota compositions may cause different effects. Indeed, our previous studies also indicated that the difference of gut microbiome caused by host genetics and pathogen infection affected As metabolism (Lu et al. 2013 (Lu et al. , 2014b . Taken together, the high variations in the gut microbiome might differently affect host As biotransformation and its toxic effects, and thus influence host tolerance to As exposure, which could be another reason for As susceptibility.
As-induced gut microbiome dysbiosis influences host health
Since it has important roles in host metabolism, the gut microbiome is considered the second genome and an extra organ of the human body (Eckburg et al. 2005; Grice and Segre 2012) . However, the variability in the gut microbiome is much larger than the variability in the host genome and organs (Schloissnig et al. 2013; Yatsunenko et al. 2012) . This variation in the gut microbiome contributes to the interindividual susceptibility to certain diseases. For example, the difference in the gender susceptibility to type 1 diabetes (T1D) in non-obese diabetic mice was directly caused by their differential commensal microbial community (Markle et al. 2013) . Previous studies also found that different microbial populations also dramatically affect the susceptibility to rheumatoid arthritis (Gomez et al. 2012; Taneja 2014) . Moreover, the normal development and homeostasis of the gut microbiome are critical for human health, and xenobiotic-induced dysbiosis of gut microbiome could modulate host susceptibility to certain diseases. For example, antibiotic-induced dysbiosis of gut microbiome in mouse increased the susceptibility to Clostridium difficile infection (Theriot et al. 2014) . As exposure has been shown to perturb the normal composition and functional pathways of the mouse gut microbiome and to alter the fecal metabolome (Lu et al. 2014a) , which might also influence host susceptibility to related diseases. In addition, as we mentioned previously, this perturbation is not consistent between different groups of people, such that different gut microbiota profiles may have different levels of tolerance to As toxicity or induce different responses to As exposure (Chi et al. 2016) . Likewise, our previous study found that gut bacteria and their functional pathways in male and female mice were differently altered by As exposure, thus suggesting the different responses to As exposure of gut bacteria in different hosts (Chi et al. 2016) . Although the specific effects of As-induced gut microbiome dysbiosis on host health are still unclear, it is likely that different degrees of dysbiosis and perturbations of the gut microbiota will differently affect host health and could cause different disease outcomes.
Challenges and perspectives
Interindividual susceptibility to As exposure is linked to and influenced by multiple factors of the host and gut microbiome, as illustrated in Fig. 2 . Although great progress has been made in the last decades, there are still several challenges to fully understand and intervene interindividual susceptibility to As exposure. First, interindividual susceptibility to As exposure is highly related to As metabolism and its mechanisms of action, which are not fully understood yet. Studies aimed to better decipher the fate of As species and the specific mechanisms involved in As-induced diseases will aid in further understanding the variability in As susceptibility. In addition, the association between host genes and As susceptibility needs to be further examined using both animal models and well-characterized human cohorts. Findings are not consistent for studies conducted in different geographic areas with different subjects, disease endpoints, and sample sizes, again highlighting the complex interactions of multiple potential environmental contributors. Moreover, although accumulating evidence indicates that the gut microbiome plays an important role in As metabolism and its health effects, the specific and systemic effects of the gut microbiome on As and how these effects cause human disease outcomes are still underexplored. The underlining mechanisms of As, host, and gut microbiota interactions need to be further investigated. Although in vitro experiments are informative to study As biotransformation catalyzed by gut bacteria, future studies on the role of the gut microbiota in As metabolism in vivo are particularly important. In addition, the gut microbiome is known to be a highly dynamic system and to have complex interactions with other factors such as diet, drug, sex, and host genetics. Therefore, individual As susceptibility and disease outcomes should be a result of the cross-talk of a series of factors including host genetics, diet nutrition, and gut microbiota. However, how multiple host and microbiome factors interact and influence As-induced disease outcomes is still unclear. Exploring the interactions between these factors and building animal models to examine these interactions would lead to a better understanding of the variability in As susceptibility, which could work in concert with studies using large human cohorts, with the goal to better understand and ultimately mediate As toxicity in susceptible populations. On the other hand, while it is challenging to understand the specific role of gut microbiome in As exposure, the highly dynamic nature of gut microbiome and its interactions with other factors make gut microbiome manipulation as a promising approach to intervene As-induced diseases in people with different susceptibility. For example, modulating gut microbiota by special diet to increase some probiotics may help decrease As bioaccessibility, promote As detoxification, and/or reduce As toxic effects. Continuous revealing of the factors contributing to As susceptibility would facilitate a better understanding of the effects of As on human health and provide clues for conducting specific interventions for people with different susceptibility. tant contributions in the field. This review is by no means a complete list of all relevant studies due to the length and scope of the paper. The work is supported by the National Institute of Health/National Institute of Environmental Health Sciences (R01ES024950). Fig. 2 An array of host, microbiome, and environmental factors influence As biotransformation and As-induced diseases, which contribute to interindividual susceptibility to As exposure
